ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

BASF And Bend To Develop Excipients

by Ann M. Thayer
March 4, 2013 | APPEARED IN VOLUME 91, ISSUE 9

BASF and Oregon-based Bend Research will jointly develop and evaluate new excipients that enhance the solubility and bioavailability of poorly soluble drugs. As an excipient producer, BASF brings ingredient formulation and materials science expertise to the collaboration. Bend provides drug formulation development and technology, such as spray drying and hot-melt extrusion. The partners will initially focus on vinylpyrrolidone-based copolymers. In late 2012, Bend started working with Dow Chemical on cellulosic excipients.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment